Sertoli cells induce systemic donor-specific tolerance in xenogenic transplantation model

Cell Transplantation

Volumn 15, Issue 1, 2006, Pages 45-53

  Shamekh, R ^a   El Badri, N S ^a   Saporta, S ^a   Pascual, C ^a   Sanberg, P R ^a   Cameron, Don F ^a,b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Sertoli cells; Systemic tolerance; Xenogenic transplantation model

Indexed keywords

CYTOKINE; HUMORAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; CELL TRANSPLANTATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNOCOMPETENCE; IMMUNOLOGICAL TOLERANCE; MALE; MIXED LYMPHOCYTE CULTURE; MOUSE; MOUSE STRAIN; NONHUMAN; PLAQUE FORMING CELL; PRIORITY JOURNAL; SERTOLI CELL; SHEEP ERYTHROCYTE; SKIN GRAFT; T LYMPHOCYTE; XENOGRAFT;

ANIMALS; CELL TRANSPLANTATION; CYTOKINES; GRAFT SURVIVAL; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MODELS, ANIMAL; RATS; RATS, SPRAGUE-DAWLEY; SERTOLI CELLS; SKIN TRANSPLANTATION; TESTIS; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HETEROLOGOUS;

ANIMALIA; OVIS ARIES;

EID: 33645671926     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000006783982205     Document Type: Article

References (47)

1. Akpinar, E.; Craighead, N.; Smoot, D.; Hale, D. A. Potent skin allograft survival prolongation using a committed progenitor fraction of bone marrow in mice. Transplantation 78:383-391; 2004.
2. Baden, L.; Rubin, R. H. Infection in hematopoietic stem cell transplant recipients. In: Soiffer, R. A., ed. Stem cell transplantation for hematologic malignancies. Totowa, NJ: Humana Press, Inc.; 2004:237-258.
3. Bellgrau, D.; Selawry, H. P. Cyclosporine-induced tolerance to intratesticular islet xenografts. Transplantation 50:654-657; 1990.
4. Borlongan, C. V.; Cameron, D. F.; Saporta, S.; Sanberg, P. R. Intracerebral transplantation of testis-derived sertoli cells promotes functional recovery in female rats with 6-hydroxydopamine-induced hemiparkinsonism. Exp. Neurol. 148:388-392; 1997.
5. Cameron, D. F.; Hushen, J. J.; Colina, L.; Mallery, J.; Willing, A.; Sanberg, P. R.; Saporta, S. Formation and structure of transplantable tissue constructs generated in simulated microgravity from sertoli cells and neuron precursors. Cell Transplant. 13:755-763; 2004.
6. Cameron, D. F.; Hushen, J. J.; Nazian, S. J. Formation of insulin-secreting, Sertoli-enriched tissue constructs by microgravity coculture of isolated pig islets and rat Sertoli cells. In Vitro Cell Dev. Biol. Anim. 37:490-498; 2001.
7. Cameron, D. F.; Hushen, J. J.; Nazian, S. J.; Willing, A.; Saporta, S.; Sanberg, P. R. Formation of Sertoli cell-enriched tissue constructs utilizing simulated microgravity technology. Ann. NY Acad. Sci. 944:420-428; 2001.
8. Cameron, D. F.; Muffly, K. E. Hormonal regulation of spermatid binding. J. Cell Sci. 100(Pt. 3):623-633; 1991.
9. Dufour, J. M.; Hemendinger, R.; Halberstadt, C. R.; Gores, P.; Emerich, D. F.; Korbutt, G. S.; Rajotte, R. V. Genetically engineered Sertoli cells are able to survive allogeneic transplantation. Gene Ther. 11:694-700; 2004.
10. Dufour, J. M.; Rajotte, R. V.; Korbutt, G. S.; Emerich, D. F. Harnessing the immunomodulatory properties of Sertoli cells to enable xenotransplantation in type I diabetes. Immunol. Invest. 32:275-297; 2003.
11. El Badri, N. S.; Good, R. A. Induction of immunological tolerance in full major and multiminor histocompatibility-disparate mice using a mixed bone marrow transplantation model. Proc. Soc. Exp. Biol. Med. 205:67-74; 1994.
12. Emerich, D. F.; Hemendinger, R.; Halberstadt, C. R. The testicular-derived Sertoli cell: Cellular immunoscience to enable transplantation. Cell Transplant. 12:335-349; 2003.
13. Ferrara, J. L.; Levy, R.; Chao, N. J. Pathophysiologic mechanisms of acute graft-vs.-host disease. Biol. Blood Marrow Transplant 5:347-356; 1999.
14. Gaya, S. B.; Rees, A. J.; Lechler, R. I.; Williams, G.; Mason, P. D. Malignant disease in patients with long-term renal transplants. Transplantation 59:1705-1709; 1995.
15. Halberstadt, C.; Emerich, D. F.; Gores, P. Use of Sertoli cell transplants to provide local immunoprotection for tissue grafts. Expert Opin. Biol. Ther. 4:813-825; 2004.
16. Jerne, N. K.; Nordin, A. A. Plaque formation in agar by single antibody-producing cells. Science 140:405; 1963.
17. Korbutt, G. S.; Elliott, J. F.; Rajotte, R. V. Cotransplantation of allogeneic islets with allogeneic testicular cell aggregates allows long-term graft survival without systemic immunosuppression. Diabetes 46:317-322; 1997.
18. Korbutt, G. S.; Suarez-Pinzon, W. L.; Power, R. F.; Rajotte, R. V.; Rabinovitch, A. Testicular Sertoli cells exert both protective and destructive effects on syngeneic islet grafts in non-obese diabetic mice. Diabetologia 43:474-480; 2000.
19. London, N. J.; Farmery, S. M.; Lodge, J. P.; Will, E. J.; Davison, A. M. Risk of neoplasia in renal transplant patients. Lancet 346:403-406; 1995.
20. Nakao, A.; Nalesnik, M. A.; Ishikawa, T.; Azhipa, O.; Demetris, A. J.; Murase, N. Chimerism and tolerance in rat recipients of intestinal allografts from ALS-treated donors with and without adjunct naive-donor-strain bone-marrow cells. Transplantation 75:1575-1581; 2003.
21. Othberg, A. I.; Willing, A. E.; Cameron, D. F.; Anton, A.; Saporta, S.; Freeman, T. B.; Sanberg, P. R. Trophic effect of porcine Sertoli cells on rat and human ventral mesencephalic cells and hNT neurons in vitro. Cell Transplant. 7:157-164; 1998.
22. Parkman, R. Chronic graft-versus-host disease. Curr. Opin. Hematol. 5:22-25; 1998.
23. Pollanen, P.; Niemi, M. Immunohistochemical identification of macrophages, lymphoid cells and HLA antigens in the human testis. Int. J Androl. 10:37-42; 1987.
24. Rodriguez, A. I.; Willing, A. E.; Cameron, D. F.; Saporta, S.; Sandberg, P. R. Neurobehavioral assessment of transplanted porcine Sertoli cells into the intact rat striatum. Neurotox. Res. 4:103-109; 2002.
25. Rodriguez, A. I.; Willing, A. E.; Saporta, S.; Cameron, D. F.; Sanberg, P. R. Effects of Sertoli cell transplants in a 3-nitropropionic acid model of early Huntington's disease: A preliminary study. Neurotox. Res. 5:443-450; 2003.
26. Salzberg-Brenhouse, H. C.; Chen, E. Y.; Emerich, D. F.; Baldwin, S.; Hogeland, K.; Ranelli, S.; Lafreniere, D.; Perdomo, B.; Novak, L.; Kladis, T.; Fu, K.; Basile, A. S.; Kordower, J. H.; Bartus, R. T. Inhibitors of cyclooxygenase-2, but not cyclooxygenase-1 provide structural and functional protection against quinolinic acid-induced neurodegeneration. J. Pharmacol. Exp. Ther. 306:218-228; 2003.
27. Sanberg, P. R.; Borlongan, C. V.; Othberg, A. I.; Saporta, S.; Freeman, T. B.; Cameron, D. F. Testis-derived Sertoli cells have a trophic effect on dopamine neurons and alleviate hemiparkinsonism in rats. Nat. Med. 3:1129-1132; 1997.
28. Sanberg, P. R.; Borlongan, C. V.; Saporta, S.; Cameron, D. F. Testis-derived Sertoli cells survive and provide localized immunoprotection for xenografts in rat brain. Nat. Biotechnol. 14:1692-1695; 1996.
29. Sanberg, P. R.; Othberg, A. I.; Borlongan, C. V.; Saporta, S.; Anton, A.; Freeman, T. B.; Cahill, D. W.; Allen, R. C.; Cameron, D. F. Transplantation of testis-derived Sertoli cells into the mammalian brain. Transplant. Proc. 29:1926-1928; 1997.
30. Sanberg, P. R.; Willing, A. E.; Cahill, D. W. Novel cellular approaches to repair of neurodegenerative disease: From Sertoli cells to umbilical cord blood stem cells. Neurotox. Res. 4:95-101; 2002.
31. Saporta, S.; Cameron, D. F.; Borlongan, C. V.; Sanberg, P. R. Survival of rat and porcine Sertoli cell transplants in the rat striatum without cyclosporine-A immunosuppression. Exp. Neurol. 146:299-304; 1997.
32. Saporta, S.; Willing, A. E.; Shamekh, R.; Bickford, P.; Paredes, D.; Cameron, D. F. Rapid differentiation of NT2 cells in Sertoli-NT2 cell tissue constructs grown in the rotating wall bioreactor. Brain Res. Bull. 64:347-356; 2004.
33. Selawry, H. P.; Cameron, D. F. Sertoli cell-enriched fractions in successful islet cell transplantation. Cell Transplant. 2:123-129; 1993.
34. Selawry, H. P.; Kotb, M.; Herrod, H. G.; Lu, Z. N. Production of a factor, or factors, suppressing IL-2 production and T cell proliferation by Sertoli cell-enriched preparations. A potential role for islet transplantation in an immunologically privileged site. Transplantation 52:846-850; 1991.
35. Shapiro, A. M.; Lakey, J. R.; Ryan, E. A.; Korbutt, G. S.; Toth, E.; Warnock, G. L.; Kneteman, N. M.; Rajotte, R. V. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med. 343:230-238; 2000.
36. Streilein, J. W. Unraveling immune privilege. Science 270:1158-1159; 1995.
37. Suarez-Pinzon, W.; Korbutt, G. S.; Power, R.; Hooton, J.; Rajotte, R. V.; Rabinovitch, A. Testicular Sertoli cells protect islet beta-cells from autoimmune destruction in NOD mice by a transforming growth factor-beta1- dependent mechanism. Diabetes 49:1810-1818; 2000.
38. Willing, A. E.; Cameron, D. F.; Sanberg, P. R. Sertoli cell transplants: Their use in the treatment of neurodegenerative disease. Mol. Med. Today 4:471-477; 1998.
39. Willing, A. E.; Othberg, A. I.; Saporta, S.; Anton, A.; Sinibaldi, S.; Poulos, S. G.; Cameron, D. F.; Freeman, T. B.; Sanberg, P. R. Sertoli cells enhance the survival of co-transplanted dopamine neurons. Brain Res. 822:246-250; 1999.
40. Willing, A. E.; Sudberry, J. J.; Othberg, A. I.; Saporta, S.; Poulos, S. G.; Cameron, D. F.; Freeman, T. B.; Sanberg, P. R. Sertoli cells decrease microglial response and increase engraftment of human hNT neurons in the hemiparkinsonian rat striatum. Brain Res. Bull. 48:441-444; 1999.
41. Wright, Jr., J. R.; Pohajdak, B. Cell therapy for diabetes using piscine islet tissue. Cell Transplant. 10:125-143; 2001.
42. Xu, H.; Chilton, P. M.; Huang, Y.; Schanie, C. L.; Ildstad, S. T. Production of donor T cells is critical for induction of donor-specific tolerance and maintenance of chimerism. J. Immunol. 172:1463-1471; 2004.
43. Yang, H.; Al-Jazaeri, A.; Wright, Jr., J. R. The immunoprotective effect of Sertoli cells coencapsulated with islet xenografts is not dependent upon Fas ligand expression. Cell Transplant. 11:799-801; 2002.
44. Yang, H.; Wright, Jr., J. R. Co-encapsulation of Sertoli enriched testicular cell fractions further prolongs fish-to-mouse islet xenograft survival. Transplantation 67:815-820; 1999.
45. Yoshida, N.; Kawahara, T.; Futagawa, S. Induction of donor-specific tolerance to allogeneic hepatocytes by allogeneic bone marrow transplantation. Hepatol. Res. 26:148-153; 2003.
46. Yule, T. D.; Montoya, G. D.; Russell, L. D.; Williams, T. M.; Tung, K. S. Autoantigenic germ cells exist outside the blood testis barrier. J. Immunol. 141:1161-1167; 1988.
47. Zhai, Y.; Ghobrial, R. M.; Busuttil, R. W.; Kupiec-Weglinski, J. W. Th1 and Th2 cytokines in organ transplantation: Paradigm lost? Crit. Rev. Immunol. 19:155-172; 1999.